Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |